Case report: Anti-GAD65 antibody-associated autoimmune encephalitis following HPV vaccination
- PMID: 36277911
- PMCID: PMC9579373
- DOI: 10.3389/fneur.2022.1017086
Case report: Anti-GAD65 antibody-associated autoimmune encephalitis following HPV vaccination
Abstract
Human papillomavirus (HPV) infection is a sexually transmitted disease that may lead to cervical cancer. HPV vaccines have been implemented widely to prevent this. While generally few complications of vaccination are reported, there have been occasional reports of adverse reactions post-vaccination. The safety profile of the HPV vaccine is reassuring. However, since its introduction, several serious post-vaccination central nervous system complications have been reported; however, causality has not been established. Herein, we describe a 39-year-old woman who developed seizures and experienced a rapid decline in memory shortly after her first dose of the HPV vaccine. Cranial magnetic resonance imaging and cerebrospinal fluid analysis were performed, and the patient was diagnosed with anti-glutamic acid decarboxylase 65 (anti-GAD65) antibody-associated autoimmune encephalitis. She responded well to high-dose glucocorticoids. Four-month follow-up revealed full recovery and absence of recurrence. Since the HPV vaccine is administered worldwide, this case should raise clinicians' awareness regarding the possible CNS complications related to vaccinations, such as anti-GAD65 antibody-associated AE.
Keywords: anti-glutamic acid decarboxylase 65 (anti-GAD65) antibody; autoimmune encephalitis (AE); cervical cancer; human papillomavirus; seizure; vaccination.
Copyright © 2022 Li, Hu, Li, Chen, Jiang and Xie.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
[Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].Zhonghua Er Ke Za Zhi. 2021 Jan 2;59(1):47-52. doi: 10.3760/cma.j.cn112140-20200705-00691. Zhonghua Er Ke Za Zhi. 2021. PMID: 33397004 Review. Chinese.
-
Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination.Front Immunol. 2022 Jan 5;12:813487. doi: 10.3389/fimmu.2021.813487. eCollection 2021. Front Immunol. 2022. PMID: 35069602 Free PMC article.
-
Glutamic acid decarboxylase 65-positive autoimmune encephalitis presenting with gelastic seizure, responsive to steroid: A case report.World J Clin Cases. 2021 Jul 6;9(19):5325-5331. doi: 10.12998/wjcc.v9.i19.5325. World J Clin Cases. 2021. PMID: 34307585 Free PMC article.
-
Predictive value of high titer of GAD65 antibodies in a case of limbic encephalitis.J Neuroimmunol. 2019 Dec 15;337:577063. doi: 10.1016/j.jneuroim.2019.577063. Epub 2019 Sep 10. J Neuroimmunol. 2019. PMID: 31525619
-
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.Vaccines (Basel). 2021 Nov 30;9(12):1413. doi: 10.3390/vaccines9121413. Vaccines (Basel). 2021. PMID: 34960159 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention (CDC) . FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. (2010) 59:626–9. - PubMed
-
- Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, et al. . Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. (2009) 374:301–14. 10.1016/S0140-6736(09)61248-4 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources